- the great bookings growth number has been helped slightly by some method changes (but even without that would still comfortably be above 70%)
- company guiding for a higher loss than previously anticipated due to continued investments in the business
- Q4 revenue guidance raised only slightly despite the huge bookings growth which means Q4 will be essentially in line with analyst estimates
- DSOs increased and cash flow was weak, company maintained its positive cash flow guidance for the year though
but the real focus should be on the great growth in bookings and deferred revenues already pointing to execeptional good business going forward. Management also commented enthusiasticly about the state of the business and that they are not seeing any problems in any region of the world. With Kenexa and Taleo seemingly out of the race for now the talent market niche is wide open for CSOD.
Wondering how long this company will manage to stay independent as these type of results usually attrace acquirers pretty fast.
Even at the current elevated valuation the stock might still be a good buy as it might be taken out pretty soon for $40 or more.
Analysts on the call mostly were in congrational mode, would expect enthusiastic commentary coupled with a very strong stock performance tomorrow.